We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Drug Companies Ask High Court To Review Actavis Role In Patent, Antitrust Case

(November 4, 2016, 8:40 AM EDT) -- WASHINGTON, D.C. — Responding to the U.S. solicitor general’s amicus curiae brief, drug companies argue in an Oct. 19 supplemental brief to the U.S. Supreme Court that they disagree with the...
To view the full article, register now.